A half a century ago, manufacturing companies never paid attention to conserving the environment when undertaking their operations. Today, all this has changed and conserving the environment is a priority for everyone and every company. Eucatex was established in 1951 in Brazil and was the first company to consider the environment and acoustic comfort in its production. It was also a pioneer in the use of eucalyptus as raw material to produce panels and ceiling tiles. Since its establishment, Eucatex has been manufacturing and selling insulating materials and ceiling lining from eucalyptus fiber.
Over the years, Eucatex has gained international acknowledgment for its high-quality products. It has also expanded its operations in producing high mechanical and technology resistance panels to manufacture partition panels, door and other products for the furniture sector. Eucatex is currently a market leader and a leading manufacturer of doors, MDP and MDF panels, laminate floors, wall partitions, hardboards and paints and varnishes.
Eucatex currently has more than 2,201 employees and exports to more than 37 countries around the world. It also has four modern factories in Salto and Botucatu. The company has experienced outstanding progress thanks to the efforts of its president, Flavio Maluf. Mr. Maluf has seen the company evolve rapidly to meet the needs of furniture manufacturers, supply huge industrial packaging, construction, cars and toys and to the foreign market with plates and doors. Apart from being a prominent Brazilian business person, he is also a professional mechanical engineer having graduated from the Armando Alvares Penteado Foundation.
Mr. Flavio Maluf is also the president of GrandFood, the owner of Golden and Premier Pet feed brands. As a renowned entrepreneur, Mr. Maluf is always open to various marketable industries. Recently, the Brazilian entrepreneur announced the purchase of Jarden Corp. by Newell Rubbermaid. Flavio added that the purchase cost Newell Rubbermaid group $15.4. Regarding the merger between Pfizer and Allergan, Flavio considered it the largest transaction ever made in this industry since the investment amounted to $155 billion. He also recalls that Pfizer once attempted to purchase AztraZeneca, a British pharmaceutical company for $118 billion but was unsuccessful. Flavio has also talked about the future of education, and how technology will play a role.